Literature DB >> 24994594

Loss of Cbl-PI3K interaction in mice prevents significant bone loss following ovariectomy.

Naga Suresh Adapala1, Danielle Holland2, Vanessa Scanlon1, Mary F Barbe2, Wallace Y Langdon3, Alexander Y Tsygankov4, Joseph A Lorenzo5, Archana Sanjay6.   

Abstract

Cbl and Cbl-b are E3 ubiquitin ligases and adaptor proteins, which perform regulatory roles in bone remodeling. Cbl-/- mice have delayed bone development due to decreased osteoclast migration. Cbl-b-/- mice are osteopenic due to increased bone resorbing activity of osteoclasts. Unique to Cbl, but not present in Cbl-b, is tyrosine 737 in the YEAM motif, which upon phosphorylation provides a binding site for the regulatory p85 subunit of PI3K. Substitution of tyrosine 737 with phenylalanine (Y737F, CblYF/YF mice) prevents Y737 phosphorylation and abrogates the Cbl-PI3K interaction. We have previously reported that CblYF/YF mice had increased bone volume due to defective bone resorption and increased bone formation. Here we show that the lumbar vertebra from CblYF/YF mice did not have significant bone loss following ovariectomy. Our data also suggests that abrogation of Cbl-PI3K interaction in mice results in the loss of coupling between bone resorption and formation, since ovariectomized CblYF/YF mice did not show significant changes in serum levels of c-terminal telopeptide (CTX), whereas the serum levels of pro-collagen type-1 amino-terminal pro-peptide (P1NP) were decreased. In contrast, following ovariectomy, Cbl-/- and Cbl-b-/- mice showed significant bone loss in the tibiae and L2 vertebrae, concomitant with increased serum CTX and P1NP levels. These data indicate that while lack of Cbl or Cbl-b distinctly affects bone remodeling, only the loss of Cbl-PI3K interaction protects mice from significant bone loss following ovariectomy.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone resorption; Cbl; Cbl-b; Osteoclast; Ovariectomy; PI3K

Mesh:

Substances:

Year:  2014        PMID: 24994594      PMCID: PMC4149851          DOI: 10.1016/j.bone.2014.06.013

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  42 in total

1.  Ubiquitin ligase Cbl-b downregulates bone formation through suppression of IGF-I signaling in osteoblasts during denervation.

Authors:  Naoto Suzue; Takeshi Nikawa; Yuko Onishi; Chiharu Yamada; Katsuya Hirasaka; Takayuki Ogawa; Harumi Furochi; Hirofumi Kosaka; Kazumi Ishidoh; Hua Gu; Shin'ichi Takeda; Naozumi Ishimaru; Yoshio Hayashi; Hironori Yamamoto; Kyoichi Kishi; Natsuo Yasui
Journal:  J Bone Miner Res       Date:  2006-05       Impact factor: 6.741

2.  Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.

Authors:  K Bachmaier; C Krawczyk; I Kozieradzki; Y Y Kong; T Sasaki; A Oliveira-dos-Santos; S Mariathasan; D Bouchard; A Wakeham; A Itie; J Le; P S Ohashi; I Sarosi; H Nishina; S Lipkowitz; J M Penninger
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

3.  Loss of c-Cbl RING finger function results in high-intensity TCR signaling and thymic deletion.

Authors:  Christine B F Thien; Frøydis D Blystad; Yifan Zhan; Andrew M Lew; Valentina Voigt; Christopher E Andoniou; Wallace Y Langdon
Journal:  EMBO J       Date:  2005-10-06       Impact factor: 11.598

4.  The loss of Cbl-phosphatidylinositol 3-kinase interaction perturbs RANKL-mediated signaling, inhibiting bone resorption and promoting osteoclast survival.

Authors:  Naga Suresh Adapala; Mary F Barbe; Wallace Y Langdon; Mary C Nakamura; Alexander Y Tsygankov; Archana Sanjay
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

5.  Deletion of the gene encoding c-Cbl alters the ability of osteoclasts to migrate, delaying resorption and ossification of cartilage during the development of long bones.

Authors:  Riccardo Chiusaroli; Archana Sanjay; Kim Henriksen; Michael T Engsig; William C Horne; Hua Gu; Roland Baron
Journal:  Dev Biol       Date:  2003-09-15       Impact factor: 3.582

6.  The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitination.

Authors:  Nicolas Sévère; Hichem Miraoui; Pierre J Marie
Journal:  J Biol Chem       Date:  2011-05-19       Impact factor: 5.157

7.  c-Cbl promotes T cell receptor-induced thymocyte apoptosis by activating the phosphatidylinositol 3-kinase/Akt pathway.

Authors:  Christine B F Thien; Samantha A Dagger; James H Steer; Frank Koentgen; Elisa S Jansen; Clare L Scott; Wallace Y Langdon
Journal:  J Biol Chem       Date:  2010-02-04       Impact factor: 5.157

8.  Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.

Authors:  Sutada Lotinun; Riku Kiviranta; Takuma Matsubara; Jorge A Alzate; Lynn Neff; Anja Lüth; Ilpo Koskivirta; Burkhard Kleuser; Jean Vacher; Eero Vuorio; William C Horne; Roland Baron
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

9.  Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases.

Authors:  P R Ebeling; J M Peterson; B L Riggs
Journal:  J Bone Miner Res       Date:  1992-11       Impact factor: 6.741

10.  Abrogation of Cbl-PI3K interaction increases bone formation and osteoblast proliferation.

Authors:  Tracy Brennan; Naga Suresh Adapala; Mary F Barbe; Vanessa Yingling; Archana Sanjay
Journal:  Calcif Tissue Int       Date:  2011-09-28       Impact factor: 4.333

View more
  4 in total

1.  Cbl-PI3K interaction regulates Cathepsin K secretion in osteoclasts.

Authors:  Jungeun Yu; Naga Suresh Adapala; Laura Doherty; Archana Sanjay
Journal:  Bone       Date:  2019-07-09       Impact factor: 4.398

2.  miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway.

Authors:  H Li; T Li; J Fan; T Li; L Fan; S Wang; X Weng; Q Han; R C Zhao
Journal:  Cell Death Differ       Date:  2015-07-24       Impact factor: 15.828

3.  Role of Cbl-PI3K Interaction during Skeletal Remodeling in a Murine Model of Bone Repair.

Authors:  Vanessa Scanlon; Do Yu Soung; Naga Suresh Adapala; Elise Morgan; Marc F Hansen; Hicham Drissi; Archana Sanjay
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

4.  Tectorigenin inhibits RANKL-induced osteoclastogenesis via suppression of NF-κB signalling and decreases bone loss in ovariectomized C57BL/6.

Authors:  Chiyuan Ma; Kai Xu; Jiahong Meng; Jisheng Ran; Safwat Adel Abdo Moqbel; An Liu; Shigui Yan; Lidong Wu
Journal:  J Cell Mol Med       Date:  2018-07-31       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.